We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sandoz Wants FDA to Raise Approval Requirements for Generics of GSK’s Advair Diskus
Sandoz Wants FDA to Raise Approval Requirements for Generics of GSK’s Advair Diskus
Sandoz is asking the FDA not to approve generic versions of GlaxoSmithKline’s Advair Diskus, unless the copycat versions have undergone adequately controlled pharmacokinetic studies.